DNA image analysis of urinary cytology: prediction of recurrent transitional cell carcinoma. 1996

G L de la Roza, and A Hopkovitz, and N P Caraway, and L Kidd, and C P Dinney, and D Johnston, and R L Katz
Department of Pathology, University of Texas, M.D. Anderson Cancer Center, Houston 77030, USA.

To evaluate the utility of image analysis in monitoring patients with transitional cell carcinoma, we studied, by cytologic means and by image analysis, 78 urinary tract specimens from 66 patients, of whom 49 (74%) had a previous history of transitional cell carcinoma. The specimens consisted of 51 (65%) voided urine specimens, 12 (15%) bladder washings, 8 (10%) ureteral washings, 3 (4%) ureteral brushings, 2 (3%) renal pelvic washings, and 2 (3%) catheterized urine specimens. DNA histograms were classified into five patterns on the basis of their DNA index and the percentage of their cells with DNA content greater than 5c: diploid (single peak in the 2c region with no cells greater than 5c), intermediate (diploid with less than 10% of cells greater than 5c), aneuploid (single peak or multiple peaks between the 2c and 4c region or more than 10% of cells greater than 5c), tetraploid (at least 10% of cells in the 4c region and a corresponding peak at 8c), and polyploid (multiple peaks in the 2c, 4c, 8c, and 10c regions). Of the 78 cases, 22 were diploid, 24 were intermediate, 29 were aneuploid, one was tetraploid, and two were polyploid. Histologic confirmation or clinical follow-up was found in 29 aneuploid cases, 13 intermediate cases, and one diploid case. Most cases of carcinoma in situ (five of six) and invasive tumors (12 of 17) were aneuploid. The sensitivity was 100%, and the specificity was 73% when cytologic and image analysis results were combined. We conclude that image analysis, when combined with cytologic examination, is a reliable noninvasive diagnostic test for monitoring patients with transitional cell carcinoma; aneuploidy is specific for malignancy; and the presence of cells greater than 5c, although frequently associated with tumor recurrence, can be seen in non-neoplastic conditions.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002295 Carcinoma, Transitional Cell A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS. Carcinomas, Transitional Cell,Cell Carcinoma, Transitional,Cell Carcinomas, Transitional,Transitional Cell Carcinoma,Transitional Cell Carcinomas
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

G L de la Roza, and A Hopkovitz, and N P Caraway, and L Kidd, and C P Dinney, and D Johnston, and R L Katz
April 1995, Pathologica,
G L de la Roza, and A Hopkovitz, and N P Caraway, and L Kidd, and C P Dinney, and D Johnston, and R L Katz
January 1975, Acta cytologica,
G L de la Roza, and A Hopkovitz, and N P Caraway, and L Kidd, and C P Dinney, and D Johnston, and R L Katz
July 1993, Cancer,
G L de la Roza, and A Hopkovitz, and N P Caraway, and L Kidd, and C P Dinney, and D Johnston, and R L Katz
December 1983, Harefuah,
G L de la Roza, and A Hopkovitz, and N P Caraway, and L Kidd, and C P Dinney, and D Johnston, and R L Katz
January 2000, The International journal of biological markers,
G L de la Roza, and A Hopkovitz, and N P Caraway, and L Kidd, and C P Dinney, and D Johnston, and R L Katz
May 1952, The Journal of urology,
G L de la Roza, and A Hopkovitz, and N P Caraway, and L Kidd, and C P Dinney, and D Johnston, and R L Katz
March 1994, Veterinary pathology,
G L de la Roza, and A Hopkovitz, and N P Caraway, and L Kidd, and C P Dinney, and D Johnston, and R L Katz
April 1993, Analytical and quantitative cytology and histology,
G L de la Roza, and A Hopkovitz, and N P Caraway, and L Kidd, and C P Dinney, and D Johnston, and R L Katz
January 1993, Acta cytologica,
G L de la Roza, and A Hopkovitz, and N P Caraway, and L Kidd, and C P Dinney, and D Johnston, and R L Katz
August 1993, Seminars in urology,
Copied contents to your clipboard!